PeterMD Review

PeterMD: a men's-health platform that happens to do GLP-1 cheaply

PeterMD isn't a dedicated weight-loss clinic — it's a men's telehealth platform that bundles compounded semaglutide and tirzepatide alongside TRT, peptide therapy, ED treatment, and anti-aging care in a single account. That framing matters. If you're a man who already wants testosterone or peptides and would like GLP-1 in the same place, PeterMD is genuinely convenient and genuinely cheap. If you just want straightforward weight-loss care and nothing else, the men's-only branding is noise you don't need. The headline reason to look here is price: compounded semaglutide runs a flat $215.67 a month, which is among the lowest standard rates we track in the category (the median is closer to $169).

How the pricing actually works

PeterMD's semaglutide pricing is refreshingly simple: $215.67 per month, flat, across every dose tier from 0.25mg up to 2.4mg. Most providers quietly raise your bill as you titrate up — PeterMD doesn't, so the $215.67 you pay in month one is the $215.67 you pay at your maintenance dose. Medication, the consult, and shipping are all included in that number. There are two add-on semaglutide combos if you want them: one bundles a MIC/B12 fat-burner injection, and one stacks phentermine plus B12 on top, each at a modest step up from the base rate.

Tirzepatide is where this gets hard to recommend, and the problem is not the headline rate. The page advertises a low figure to get started, then a recurring rate billed every three months rather than monthly. When we clicked the page's own Add To Cart button in August 2026 — the one sitting directly beneath that advertised start price — the cart came back at roughly four and a half times it, and the advertised figure did not appear in the cart at all. The page's two numbers do not reconcile with each other either: its stated monthly rate, billed quarterly, works out to a hundred dollars more per quarter than the cart actually asks for. Whichever is right, you are authorizing a three-month charge up front and you cannot tell from the page what it will be. The rate in our table is the cart figure divided by three, because that is the money that leaves your account. Treat the advertised start price as marketing.

• Semaglutide: flat $215.67/mo, billed monthly, same price at any dose
• Semaglutide + MIC/B12 and + phentermine + B12: small add-ons over the base rate
• Tirzepatide: advertised at a low start price the cart does not honor — billed quarterly, so a ~3-month charge up front

What you're actually getting in the syringe

Everything here is compounded, not brand-name. There's no Wegovy or Zepbound on the menu — PeterMD prepares semaglutide and tirzepatide (often paired with B12) through licensed compounding pharmacies. That's how the $215.67 flat rate is possible, and it's the same model most cash-pay GLP-1 services use. Compounded medication is legal and widely dispensed, but it isn't FDA-approved the way the branded pens are, so it's worth knowing what you're choosing. The flip side is real savings and no insurance hassle: PeterMD is entirely cash-pay, and the price you see is the price you pay.

The flat semaglutide rate is the real differentiator

Strip away the men's-health packaging and what sets PeterMD apart is that flat, dose-agnostic $215.67 semaglutide price. In a category where it's normal to start cheap and get squeezed as your dose climbs, a provider that holds the line at every tier is doing something patients actually feel in their bank account over a year of treatment. Pair that with month-to-month cancellation through the patient portal — no cancellation fee, no phone-tree retention gauntlet — and the semaglutide plan in particular is low-commitment in a way the rest of the category often isn't.

Who should choose it — and who should skip it

Choose PeterMD if you're a man who wants the cheapest reliable compounded semaglutide and might also want TRT, peptides, or ED care under one login. The single-account convenience plus the flat rate is a legitimately strong combination for that person.

• Skip it if you're a woman — the entire brand is built around men's health and it will feel like the wrong front door
• Skip it if you live in AL, AR, CA, HI, ID, MI, NC, or TX — PeterMD doesn't operate in those 8 states (it covers the other 42)
• Skip it if you want brand-name pens — there's no FDA-approved Wegovy or Zepbound option here, only compounded
• Think twice on tirzepatide if you want true month-to-month flexibility, since it commits you to quarterly billing

Trust, oversight, and where our confidence sits

PeterMD states that its prescribing physicians hold state medical licenses, controlled-substance licenses, and state DEA licenses, and the compounded GLP-1 is prepared by licensed pharmacies. There are no FDA warning letters on file for this provider, which is a clean baseline. We do hold this listing at medium confidence for one honest reason: PeterMD does not publicly name its compounding pharmacy partner or its individual clinicians on the site, so we can't independently verify specific NPIs or pharmacy accreditation the way we can for providers that disclose those details. Nothing here is a red flag — it's simply less transparency than the most open providers offer. You can read how we weigh this in our scoring methodology.

The bottom line

PeterMD is one of the better-value compounded semaglutide options in the men's-health corner of the market: a genuinely flat $215.67 a month at any dose, medication and shipping included, with painless month-to-month cancellation. The tirzepatide quarterly-billing structure and the eight-state coverage gap are real trade-offs, and the undisclosed pharmacy partner is why we don't rate it top-confidence. But for a man who wants affordable GLP-1 access — especially alongside TRT or peptide therapy — it's an easy provider to recommend a closer look at.

For a side-by-side, Oak ($200/month) and MadeMed ($219/month) are the most comparable options to weigh against PeterMD.